Isothermal Nucleic Acid Amplification Technology Market by Product (Assay, System), Technology (LAMP, SDA, NASBA, NEAR, HDA), Application (Diagnostics (Influenza, Hepatitis, CT/NG, COVID-19), blood screening), End User & Region - Global Forecast to 2028

Abstract
The isothermal nucleic acid amplification technology market is projected to reach USD 6.8 Billion by 2028 from USD 4.4 Billion in 2023, at a CAGR of 9.2% during the forecast period. Increasing prevalence of infectious diseases, launches & approvals for INAAT products and availability of funding for diagnostic tools are various factors projected to drive the growth of the isothermal nucleic acid amplification technology market.

LAMP segment accounted for the largest share of the INAAT market

Based on technology, the isothermal nucleic acid amplification technology market is segmented into loop-mediated isothermal amplification (LAMP), transcription-mediated amplification (TMA), strand displacement amplification (SDA), nicking enzyme amplification reaction (NEAR), single-primer isothermal amplification (SPIA), and other technologies. In 2022, the loop-mediated isothermal amplification (LAMP) segment dominated the market. This is owing to high demand for LAMP kits and wide availability of these kits in developed and developing markets across the globe.

Infectious disease diagnosis segment accounted for the largest application segment of the market

Based on application, the INAAT market is segmented into infectious disease diagnosis, blood screening, and other applications. The disease diagnosis segment is expected to dominate the market in 2022. Various factors drive the growth of the segment are rising number of HIV, influenza, and hepatitis cases across the globe, focus on infectious disease control, and use of INAAT based kits for the diagnosis of these diseases.

The prominent players in isothermal nucleic acid amplification technology market are Grifols, S.A. (Spain), Hologic, Inc. (US), Abbott Laboratories (US), Becton, Dickinson and Company (US), Meridian Bioscience (US), Eiken Chemical Co., Ltd. (Japan), bioMérieux SA (France), Tecan Trading AG (Switzerland), New England Biolabs (US), QIAGEN N.V. (Germany), DiaSorin S.p.A. (Italy), General Electric (US), OptiGene Limited (UK), Quidel Corporation (US), Thermo Fisher Scientific (US), Genomtec (Poland), Mast Group Ltd. (UK), Ustar Biotechnologies (China), Jena Bioscience GmbH (Germany), Atila BioSystems (US), TwistDx Limited (UK), LGC Limited (UK), Life Sciences Advanced Technologies (US), GenoSensor Corporation (US), and PCR Biosystems (UK). 

“North America: Accounted for the largest share in isothermal nucleic acid amplification technology market”

North America has the largest share of the isothermal nucleic acid amplification technology market. Factors such as availability of research funding and the development of diagnostic industry, increasing importance of early diagnosis for patient with HIV, Hepatitis and Influenza, and developed healthcare infrastructure are the major factors driving the market growth.

The primary interviews conducted for this report can be categorized as follows:
•By Respondent: Supply Side- 80% and Demand Side - 20%
•By Designation: Managers- 45%, CXOs and Director level - 30%, and Executives - 25%
•By Region: North America -20%, Europe -15%, Asia-Pacific -55%, RoW -10%

List of Companies Profiled in the Report:
•Grifols, S.A. (Spain)
•Hologic, Inc. (US)
•Abbott Laboratories (US)
•Becton, Dickinson and Company (US)
•Meridian Bioscience (US)
•Eiken Chemical Co., Ltd. (Japan)
•bioMérieux SA (France)
•Tecan Trading AG (Switzerland)
•New England Biolabs (US)
•QIAGEN N.V. (Germany)
•DiaSorin S.p.A. (Italy)
•General Electric (US)
•OptiGene Limited (UK)
•Quidel Corporation (US)
•Thermo Fisher Scientific (US)
•Genomtec (Poland)
•Mast Group Ltd. (UK)
•Ustar Biotechnologies (China)
•Jena Bioscience GmbH (Germany)
•Atila BioSystems (US)
•TwistDx Limited (UK)
•LGC Limited (UK)
•Life Sciences Advanced Technologies (US)
•GenoSensor Corporation (US)
•PCR Biosystems (UK) 

Research Coverage:
This report provides a detailed picture of the isothermal nucleic acid amplification technology market. It aims at estimating the size and future growth potential of the market across different segments such as the product, application, end users and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall isothermal nucleic acid amplification technology market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities.

Content
Table of Contents

1INTRODUCTION34
1.1STUDY OBJECTIVES34
1.2MARKET DEFINITION34
1.2.1INCLUSIONS & EXCLUSIONS35
1.3MARKET SCOPE36
FIGURE 1ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SEGMENTATION36
1.3.1YEARS CONSIDERED37
1.4CURRENCY CONSIDERED37
1.5LIMITATIONS37
1.6STAKEHOLDERS38
1.7SUMMARY OF CHANGES38
2RESEARCH METHODOLOGY39
2.1RESEARCH APPROACH39
FIGURE 2RESEARCH DESIGN39
2.1.1PRIMARY RESEARCH39
FIGURE 3ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: PRIMARY RESPONDENTS40
2.2MARKET ESTIMATION METHODOLOGY40
FIGURE 4ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SIZE ESTIMATION: SUPPLY-SIDE ANALYSIS, 202240
FIGURE 5MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 202241
2.2.1INSIGHTS FROM PRIMARY EXPERTS42
FIGURE 6MARKET SIZE VALIDATION FROM PRIMARY RESOURCES42
2.3MARKET GROWTH RATE PROJECTIONS43
FIGURE 7ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: CAGR PROJECTIONS, 2023–202844
FIGURE 8ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET (DEMAND SIDE): GROWTH ANALYSIS OF DEMAND-SIDE FACTORS44
2.4DATA TRIANGULATION45
FIGURE 9DATA TRIANGULATION METHODOLOGY45
2.5RESEARCH ASSUMPTIONS45
2.6RISK ANALYSIS46
2.7RECESSION IMPACT46
3EXECUTIVE SUMMARY48
FIGURE 10ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)48
FIGURE 11ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)49
FIGURE 12ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)49
FIGURE 13ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)50
FIGURE 14GEOGRAPHICAL SNAPSHOT OF ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET51
4PREMIUM INSIGHTS52
4.1ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET OVERVIEW52
FIGURE 15INCREASING PREVALENCE OF INFECTIOUS DISEASES TO DRIVE MARKET GROWTH52
4.2NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT AND COUNTRY (2022)53
FIGURE 16ASSAYS, KITS, AND REAGENTS ACCOUNTED FOR LARGEST MARKET SHARE IN 202253
4.3ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SHARE, BY APPLICATION, 2023 VS. 202853
FIGURE 17DISEASE DIAGNOSIS APPLICATION SEGMENT TO CONTINUE TO DOMINATE MARKET IN 202853
4.4ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES54
FIGURE 18CHINA TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD54
5MARKET OVERVIEW55
5.1INTRODUCTION55
5.2MARKET DYNAMICS55
FIGURE 19ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES55
TABLE 1ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: IMPACT ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES56
5.2.1DRIVERS56
5.2.1.1Recent launches of INAAT consumables by prominent market players56
5.2.1.2Growing funding initiatives for molecular diagnostics & infectious disease diagnostics57
5.2.1.3High prevalence of infectious diseases58
5.2.2RESTRAINTS58
5.2.2.1Unfavorable reimbursement scenario for in vitro diagnostic tests58
5.2.3OPPORTUNITIES59
5.2.3.1INAAT tests as point-of-care tools59
5.2.3.2Start-ups focusing on INAAT59
5.2.4CHALLENGES60
5.2.4.1Dominance of PCR60
5.3PRICING ANALYSIS60
TABLE 2AVERAGE SELLING PRICE OF INAAT PRODUCTS, 202260
5.4VALUE CHAIN ANALYSIS61
FIGURE 20VALUE CHAIN OF INAAT MARKET: MAXIMUM VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES61
5.5ECOSYSTEM ANALYSIS62
FIGURE 21ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: ECOSYSTEM ANALYSIS62
TABLE 3SUPPLY CHAIN ECOSYSTEM63
5.6KEY CONFERENCES & EVENTS IN 2023–202463
TABLE 4ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: DETAILED LIST OF CONFERENCES & EVENTS63
5.7PORTER’S FIVE FORCES ANALYSIS65
TABLE 5ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS65
5.7.1THREAT FROM NEW ENTRANTS65
5.7.2THREAT FROM SUBSTITUTES65
5.7.3BARGAINING POWER OF BUYERS65
5.7.4BARGAINING POWER OF SUPPLIERS65
5.7.5DEGREE OF COMPETITION66
5.8KEY STAKEHOLDERS & BUYING CRITERIA66
FIGURE 22INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF INAAT PRODUCTS66
FIGURE 23BUYING CRITERIA FOR INAAT PRODUCTS66
5.9PATENT ANALYSIS67
FIGURE 24PATENT APPLICATIONS RELATED TO ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, JANUARY 2012–DECEMBER 202267
5.10REGULATORY ANALYSIS67
TABLE 6NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS67
TABLE 7ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS68
TABLE 8LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS68
TABLE 9REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS68
5.10.1NORTH AMERICA69
5.10.1.1US69
5.10.1.2Canada69
5.10.2EUROPE69
TABLE 10EUROPE: CLASSIFICATION OF DEVICES69
5.10.3ASIA PACIFIC70
5.10.3.1China70
5.10.3.2Japan70
5.10.3.3India70
5.10.4LATIN AMERICA70
5.10.4.1Brazil70
5.10.4.2Mexico71
5.10.5MIDDLE EAST71
5.11TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES71
FIGURE 25REVENUE SHIFT AND NEW REVENUE POCKETS71
6ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT72
6.1INTRODUCTION73
TABLE 11ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)73
6.2ASSAYS, KITS, AND REAGENTS73
6.2.1GROWING AWARENESS OF INAAT TO DRIVE DEMAND FOR ASSAYS, KITS, AND REAGENTS73
TABLE 12ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)74
TABLE 13NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)74
TABLE 14EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)74
TABLE 15ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY ASSAYS, KITS, AND REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)75
6.3SYSTEMS75
6.3.1GROWING POPULARITY OF INAAT SYSTEMS TO SUPPORT MARKET GROWTH75
TABLE 16ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)76
TABLE 17NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)76
TABLE 18EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)76
TABLE 19ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY SYSTEMS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)77
7ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY78
7.1INTRODUCTION79
TABLE 20ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGIES79
TABLE 21ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)80
7.2LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP)80
7.2.1LAUNCH OF NEW LAMP DIAGNOSTIC KITS TO SUPPORT MARKET GROWTH80
TABLE 22LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY REGION, 2021–2028 (USD MILLION)81
TABLE 23NORTH AMERICA: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)81
TABLE 24EUROPE: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)82
TABLE 25ASIA PACIFIC: LOOP-MEDIATED ISOTHERMAL AMPLIFICATION (LAMP) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)82
7.3TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA)82
7.3.1GROWING EFFORTS TO DEVELOP TMA KITS TO BOOST GROWTH82
TABLE 26TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY REGION, 2021–2028 (USD MILLION)83
TABLE 27NORTH AMERICA: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)83
TABLE 28EUROPE: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)84
TABLE 29ASIA PACIFIC: TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)84
7.4NICKING ENZYME AMPLIFICATION REACTION (NEAR)84
7.4.1RAPID IDENTIFICATION OF SMALL DNA OR RNA FRAGMENTS TO BOOST ADOPTION OF NEAR84
TABLE 30NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY REGION, 2021–2028 (USD MILLION)85
TABLE 31NORTH AMERICA: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)85
TABLE 32EUROPE: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)86
TABLE 33ASIA PACIFIC: NICKING ENZYME AMPLIFICATION REACTION (NEAR) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)86
7.5STRAND DISPLACEMENT AMPLIFICATION (SDA)86
7.5.1GROWING USE OF SDA IN RNA AMPLIFICATION TO PROPEL MARKET GROWTH86
TABLE 34STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY REGION, 2021–2028 (USD MILLION)87
TABLE 35NORTH AMERICA: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)87
TABLE 36EUROPE: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)88
TABLE 37ASIA PACIFIC: STRAND DISPLACEMENT AMPLIFICATION (SDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)88
7.6HELICASE-DEPENDENT AMPLIFICATION (HDA)88
7.6.1USE OF THERMOSTABLE HELICASE ENZYMES INSTEAD OF HEAT TO BOOST DEMAND FOR HDA88
TABLE 38HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY REGION, 2021–2028 (USD MILLION)89
TABLE 39NORTH AMERICA: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)89
TABLE 40EUROPE: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)90
TABLE 41ASIA PACIFIC: HELICASE-DEPENDENT AMPLIFICATION (HDA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)90
7.7NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA)90
7.7.1ADVANTAGES OF NASBA OVER PCR TO BOOST ADOPTION IN CLINICAL SETTINGS90
TABLE 42NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY REGION, 2021–2028 (USD MILLION)91
TABLE 43NORTH AMERICA: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)91
TABLE 44EUROPE: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)92
TABLE 45ASIA PACIFIC: NUCLEIC ACID SEQUENCE-BASED AMPLIFICATION (NASBA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)92
7.8SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA)92
7.8.1USE OF RNA/DNA-3′ PRIMER FOR FIRST-STRAND CDNA SYNTHESIS TO DRIVE MARKET92
TABLE 46SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY REGION, 2021–2028 (USD MILLION)93
TABLE 47NORTH AMERICA: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)93
TABLE 48EUROPE: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)94
TABLE 49ASIA PACIFIC: SINGLE-PRIMER ISOTHERMAL AMPLIFICATION (SPIA) MARKET, BY COUNTRY, 2021–2028 (USD MILLION)94
7.9OTHER TECHNOLOGIES95
TABLE 50OTHER INAAT TECHNOLOGIES MARKET, BY REGION, 2021–2028 (USD MILLION)95
TABLE 51NORTH AMERICA: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)95
TABLE 52EUROPE: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)96
TABLE 53ASIA PACIFIC: OTHER INAAT TECHNOLOGIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)96
8ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION97
8.1INTRODUCTION98
TABLE 54ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)98
8.2DISEASE DIAGNOSIS98
TABLE 55ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)98
TABLE 56ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)99
TABLE 57NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)99
TABLE 58EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)99
TABLE 59ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)100
8.2.1COVID-19100
8.2.1.1Extensive use of INAAT kits for COVID-19 diagnosis to support market growth100
TABLE 60ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY REGION, 2021–2028 (USD MILLION)101
TABLE 61NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021–2028 (USD MILLION)101
TABLE 62EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021–2028 (USD MILLION)101
TABLE 63ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR COVID-19 TESTING, BY COUNTRY, 2021–2028 (USD MILLION)102
8.2.2HEPATITIS102
8.2.2.1Growing adoption of advanced technologies for diagnosis of hepatitis B to drive growth102
FIGURE 26NEW CASES OF HEPATITIS B AND HEPATITIS C WORLDWIDE, BY GENDER, 2020102
TABLE 64ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY REGION, 2021–2028 (USD MILLION)103
TABLE 65NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021–2028 (USD MILLION)103
TABLE 66EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021–2028 (USD MILLION)103
TABLE 67ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HEPATITIS TESTING, BY COUNTRY, 2021–2028 (USD MILLION)104
8.2.3CT/NG104
8.2.3.1Growing prevalence of CT/NG infections worldwide to boost market104
TABLE 68ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY REGION, 2021–2028 (USD MILLION)105
TABLE 69NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021–2028 (USD MILLION)105
TABLE 70EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021–2028 (USD MILLION)105
TABLE 71ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR CT/NG TESTING, BY COUNTRY, 2021–2028 (USD MILLION)106
8.2.4INFLUENZA106
8.2.4.1Growing focus on containing spread of influenza to propel growth106
TABLE 72ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY REGION, 2021–2028 (USD MILLION)106
TABLE 73NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021–2028 (USD MILLION)107
TABLE 74EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021–2028 (USD MILLION)107
TABLE 75ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR INFLUENZA TESTING, BY COUNTRY, 2021–2028 (USD MILLION)107
8.2.5HIV108
8.2.5.1High global incidence of HIV to support market growth108
TABLE 76GLOBAL HIV CASES, 2021108
TABLE 77ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY REGION, 2021–2028 (USD MILLION)108
TABLE 78NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021–2028 (USD MILLION)109
TABLE 79EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021–2028 (USD MILLION)109
TABLE 80ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HIV TESTING, BY COUNTRY, 2021–2028 (USD MILLION)109
8.2.6OTHER DISEASES110
TABLE 81ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY REGION, 2021–2028 (USD MILLION)110
TABLE 82NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)110
TABLE 83EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)111
TABLE 84ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)111
8.3BLOOD SCREENING111
8.3.1INCREASING NUMBER OF BLOOD DONATIONS AND TRANSFUSIONS TO INCREASE USE OF INAAT IN BLOOD SCREENING APPLICATIONS111
TABLE 85ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)112
TABLE 86NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)112
TABLE 87EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)113
TABLE 88ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR BLOOD SCREENING APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)113
8.4OTHER APPLICATIONS113
TABLE 89ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION, 2021–2028 (USD MILLION)114
TABLE 90NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)114
TABLE 91EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)114
TABLE 92ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)115
9ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER116
9.1INTRODUCTION117
TABLE 93ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)117
9.2HOSPITALS117
9.2.1HOSPITALS TO DOMINATE INAAT MARKET DURING FORECAST PERIOD117
TABLE 94ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY REGION, 2021–2028 (USD MILLION)118
TABLE 95NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)118
TABLE 96EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)118
TABLE 97ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)119
9.3REFERENCE LABORATORIES119
9.3.1AVAILABILITY OF WIDE RANGE OF TEST PANELS FOR INFECTIOUS DISEASE TESTING TO SUPPORT MARKET119
TABLE 98ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY REGION, 2021–2028 (USD MILLION)119
TABLE 99NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)120
TABLE 100EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)120
TABLE 101ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021–2028 (USD MILLION)120
9.4ACADEMIC & RESEARCH INSTITUTES121
9.4.1GROWING USE OF INAAT ASSAYS BY ACADEMIC & RESEARCH INSTITUTES TO BOOST MARKET121
TABLE 102ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)121
TABLE 103NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)121
TABLE 104EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)122
TABLE 105ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)122
9.5OTHER END USERS122
TABLE 106ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)123
TABLE 107NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)123
TABLE 108EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)123
TABLE 109ASIA PACIFIC: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)124
10ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY REGION125
10.1INTRODUCTION126
TABLE 110ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY REGION, 2021–2028 (USD MILLION)126
10.2NORTH AMERICA126
FIGURE 27NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET SNAPSHOT127
TABLE 111NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)127
TABLE 112NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)128
TABLE 113NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)128
TABLE 114NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)129
TABLE 115NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)129
TABLE 116NORTH AMERICA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)129
10.2.1US130
10.2.1.1Increasing approvals of INAAT products to drive market growth130
TABLE 117US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)130
TABLE 118US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)131
TABLE 119US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)131
TABLE 120US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)132
TABLE 121US: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)132
10.2.2CANADA132
10.2.2.1Growing demand for molecular diagnostic kits to boost adoption of INAAT132
TABLE 122CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)133
TABLE 123CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)133
TABLE 124CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)134
TABLE 125CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)134
TABLE 126CANADA: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)134
10.2.3NORTH AMERICA: RECESSION IMPACT135
10.3EUROPE135
TABLE 127EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY COUNTRY, 2021–2028 (USD MILLION)136
TABLE 128EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)136
TABLE 129EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)137
TABLE 130EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)137
TABLE 131EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)138
TABLE 132EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)138
10.3.1GERMANY138
10.3.1.1Germany to dominate European isothermal nucleic acid amplification technology market during forecast period138
TABLE 133GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)139
TABLE 134GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)140
TABLE 135GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)140
TABLE 136GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)141
TABLE 137GERMANY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)141
10.3.2UK141
10.3.2.1Growing adoption of INAAT products to support market growth in UK141
TABLE 138NUMBER OF BLOOD DONATIONS IN UK, 2016–2020142
TABLE 139UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)142
TABLE 140UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)143
TABLE 141UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)143
TABLE 142UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)144
TABLE 143UK: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)144
10.3.3FRANCE144
10.3.3.1Established blood screening regulations to boost growth144
TABLE 144HIV DATA FOR FRANCE, 2021145
TABLE 145FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)145
TABLE 146FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)145
TABLE 147FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)146
TABLE 148FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)146
TABLE 149FRANCE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)146
10.3.4ITALY147
10.3.4.1Favorable government initiatives for blood transfusion to support growth147
TABLE 150HIV DATA FOR ITALY, 2021147
TABLE 151ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)148
TABLE 152ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)148
TABLE 153ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)149
TABLE 154ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)149
TABLE 155ITALY: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)149
10.3.5SPAIN150
10.3.5.1Growing demand for diagnostic testing in Spain to favor market growth150
TABLE 156HIV DATA FOR SPAIN, 2021150
TABLE 157SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)151
TABLE 158SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)151
TABLE 159SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)152
TABLE 160SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)152
TABLE 161SPAIN: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)152
10.3.6REST OF EUROPE153
TABLE 162REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY PRODUCT, 2021–2028 (USD MILLION)153
TABLE 163REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)154
TABLE 164REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY APPLICATION, 2021–2028 (USD MILLION)154
TABLE 165REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET FOR DISEASE DIAGNOSIS APPLICATIONS, BY TYPE, 2021–2028 (USD MILLION)155
TABLE 166REST OF EUROPE: ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY MARKET, BY END USER, 2021–2028 (USD MILLION)155
10.3.7EUROPE: RECESSION IMPACT155